Funding for this research was provided by:
University of Michigan Department of Obstetrics and Gynecology Ansbacher Resident Research Fund (325471)
Received: 6 September 2017
Accepted: 31 January 2018
First Online: 9 February 2018
Ethics approval and consent to participate
: This study was approved by the University of Michigan Institutional Review Board (IRB # HUM00099459). This study was determined not to require review by the University of Michigan Health System Comprehensive Cancer Center Protocol Review Committee as it did not involve a cancer-related therapeutic clinical research protocol or a cancer prevention or control research protocol. A waiver of informed consent was granted based on the following University of Michigan Institutional Review Board criteria all being met: 1. The research involved no more than minimal risk to the subjects; 2. The waiver would not adversely affect the rights and welfare of the subjects; 3. The research could not practicably (i.e., feasibly) be carried out without the waiver or alteration (given the retrospective nature spanning over 20 years during which many patients died); 4. Whenever appropriate, it was agreed that the subjects would be provided with additional pertinent information obtained from the study.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.